Lipidomics: a promising cancer biomarker

The prevention, diagnosis and targeted therapies of cancer are important in cancer controlling and treatment. The present challenge about cancer biomarker still remains in identifying the special biomarkers for predicting cancer risk and assessing patient’s response during anticancer treatment. Lipi...

Descripción completa

Detalles Bibliográficos
Autores principales: Yan, Furong, Zhao, Hong, Zeng, Yiming
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2018
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064713/
https://www.ncbi.nlm.nih.gov/pubmed/30058036
http://dx.doi.org/10.1186/s40169-018-0199-0
_version_ 1783342739497156608
author Yan, Furong
Zhao, Hong
Zeng, Yiming
author_facet Yan, Furong
Zhao, Hong
Zeng, Yiming
author_sort Yan, Furong
collection PubMed
description The prevention, diagnosis and targeted therapies of cancer are important in cancer controlling and treatment. The present challenge about cancer biomarker still remains in identifying the special biomarkers for predicting cancer risk and assessing patient’s response during anticancer treatment. Lipidomics, in simple definition is the quantification of all lipids in a confined biological entity. Lipids play roles in membrane structure, energy storage, and signal transduction as well as in human cancers. Previous researches indicated that lipids may serve as a promising biomarker in the early diagnoses and individualized treatment of cancer.
format Online
Article
Text
id pubmed-6064713
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-60647132018-08-13 Lipidomics: a promising cancer biomarker Yan, Furong Zhao, Hong Zeng, Yiming Clin Transl Med Commentary The prevention, diagnosis and targeted therapies of cancer are important in cancer controlling and treatment. The present challenge about cancer biomarker still remains in identifying the special biomarkers for predicting cancer risk and assessing patient’s response during anticancer treatment. Lipidomics, in simple definition is the quantification of all lipids in a confined biological entity. Lipids play roles in membrane structure, energy storage, and signal transduction as well as in human cancers. Previous researches indicated that lipids may serve as a promising biomarker in the early diagnoses and individualized treatment of cancer. Springer Berlin Heidelberg 2018-07-30 /pmc/articles/PMC6064713/ /pubmed/30058036 http://dx.doi.org/10.1186/s40169-018-0199-0 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Commentary
Yan, Furong
Zhao, Hong
Zeng, Yiming
Lipidomics: a promising cancer biomarker
title Lipidomics: a promising cancer biomarker
title_full Lipidomics: a promising cancer biomarker
title_fullStr Lipidomics: a promising cancer biomarker
title_full_unstemmed Lipidomics: a promising cancer biomarker
title_short Lipidomics: a promising cancer biomarker
title_sort lipidomics: a promising cancer biomarker
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6064713/
https://www.ncbi.nlm.nih.gov/pubmed/30058036
http://dx.doi.org/10.1186/s40169-018-0199-0
work_keys_str_mv AT yanfurong lipidomicsapromisingcancerbiomarker
AT zhaohong lipidomicsapromisingcancerbiomarker
AT zengyiming lipidomicsapromisingcancerbiomarker

Ejemplares similares